Article · 3 Nov 2026
Research articlePublished 19 Dec 2014
Effect of ERCC1 polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer..
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We conducted a cohort study to investigate the role of 3 single-nucleotide polymorphisms of the excision repair cross-complementation group 1 (ERCC1) gene on the response to chemotherapy and clinical outcomes of non-small cell lung cancer (NSCLC). A total of 163 patients with newly diagnosed and histopathologically confirmed primary NSCLC were examined in our study and were followed up until December 2012. ERCC1 rs11615, rs3212986, and rs2298881 were selected and genotyped. Of the 163 patients, 86 patients showed a complete response and partial response to chemotherapy (52.76%), while 91 patients (55.83%) died from NSCLC during the follow-up period with a median survival time of 19.3 months (range, 2-60 months).
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Genetics and Molecular Research.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalGenetics and Molecular Research
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “H. Gao”
- BylineArticles whose byline prints “R.C. Ge”
- BylineArticles whose byline prints “H.Y. Liu”
- BylineArticles whose byline prints “Y. Wang”